Loading clinical trials...
Loading clinical trials...
Evaluate data accuracy of cardiac acoustic biomarkers (CABs) recorded by the Wearable Cardioverter Defibrillator (WCD) as compared to the AUDICOR AM acoustic cardiography recorder.
Single arm, prospective, non significant risk device study to evaluate data accuracy of cardiac acoustic biomarkers (CABs) recorded by the Wearable Cardioverter Defibrillator (WCD) compared with the CABs data simultaneously recorded by an acoustic cardiography recorder, the AUDICOR AM device.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
MAYO Clinic
Rochester, Minnesota, United States
Start Date
January 23, 2020
Primary Completion Date
September 30, 2025
Completion Date
September 30, 2025
Last Updated
October 30, 2025
60
ACTUAL participants
Wearable Cardioverter Defibrillator
DEVICE
Lead Sponsor
Zoll Medical Corporation
NCT07191730
NCT07484009
NCT07105007
NCT04419480
NCT05647213
NCT06200207
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions